UBS Group AG Boosts Holdings in Astrana Health, Inc. $ASTH

UBS Group AG grew its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 48.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 176,100 shares of the company’s stock after acquiring an additional 57,432 shares during the quarter. UBS Group AG owned 0.31% of Astrana Health worth $4,369,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the business. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Astrana Health by 79.4% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,144 shares of the company’s stock worth $376,000 after acquiring an additional 6,702 shares in the last quarter. State of Alaska Department of Revenue raised its stake in shares of Astrana Health by 24.8% during the fourth quarter. State of Alaska Department of Revenue now owns 30,546 shares of the company’s stock worth $757,000 after acquiring an additional 6,071 shares in the last quarter. Signaturefd LLC raised its stake in shares of Astrana Health by 57.9% during the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after acquiring an additional 388 shares in the last quarter. Yarbrough Capital LLC purchased a new position in shares of Astrana Health during the fourth quarter worth approximately $394,000. Finally, NorthCrest Asset Manangement LLC raised its stake in shares of Astrana Health by 0.5% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 450,465 shares of the company’s stock worth $12,343,000 after acquiring an additional 2,084 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Up 1.3%

Shares of NASDAQ ASTH opened at $37.85 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. Astrana Health, Inc. has a 52 week low of $18.08 and a 52 week high of $39.93. The firm’s fifty day moving average is $30.70 and its 200 day moving average is $26.17. The company has a market cap of $2.11 billion, a price-to-earnings ratio of 62.05 and a beta of 0.98.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.45. The business had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company’s quarterly revenue was up 55.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.42 EPS. On average, equities research analysts expect that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Analyst Upgrades and Downgrades

ASTH has been the topic of several analyst reports. Weiss Ratings raised shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Needham & Company LLC lifted their target price on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. TD Cowen lifted their target price on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Barclays lifted their target price on shares of Astrana Health from $26.00 to $37.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. Finally, Robert W. Baird set a $45.00 target price on shares of Astrana Health in a research note on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $43.14.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.